Primary peritoneal serous borderline tumors (PPSBT) are rare neoplasms that can present as an incidental finding at laparoscopy and raise concern regarding a primary ovarian tumor with peritoneal implants. The aim is to present an overview of all reported cases of PPSBT, including a case from our own department, with a focus on clinical presentation, diagnosis, therapeutic options, and prognosis. A search for articles containing various terminologies describing PPSBT was performed via PubMed. We included English and French language publications from 1966 to May 2019. All identified manuscripts (N = 15) were reviewed completely. To date, 229 cases of PPSBT have been reported in literature. Most patients present with infertility or abdominal pain. Diagnosis is based on histopathology since appropriate imaging or specific tumor markers are lacking. The main therapy applied in the majority of cases was simple (74 cases, 32.3%) or extended (136 cases, 59.4%) resection. Prognosis seems good, independent of the extent of surgery, with recurrence rates below 25%, and follow-up periods from 5 months to > 30 years. PPSBT is a rare condition, often found in women of reproductive age with a history of infertility or abdominal pain. In most cases, the diagnosis is established incidentally during laparoscopy or laparotomy followed by histopathology. Considering the good prognosis even with incomplete resection, limited surgery to retain fertility might be good initial options. Since the course of the disease can comprise decades, a long-term follow-up is crucial.
Introduction
Extraovarian peritoneal implants are present in 30-50% of women with ovarian serous borderline tumors [1] . However, identical peritoneal lesions have also been reported in the absence of ovarian involvement or in the presence of only minimal ovarian surface involvement. There have been numerous attempts to find terminology and definitions for these lesions such as "atypical endosalpingiosis" [2, 3] , "primary papillary peritoneal neoplasia" [4, 5] , "serous micropapillomatosis of low malignant potential" [6] , or "serous papillary borderline tumors of the peritoneum" [1] . The term "primary peritoneal serous borderline tumor" (PPSBT) [7] is the most recent one and focuses on the histologic similarity to secondary implants of borderline tumors of the ovary.
The microscopic features of these peritoneal/serosal foci are divided into 2 categories: desmoplastic lesions with or epithelial lesions without prominent fibroblastic response surrounding the epithelial cell proliferation [8] . Characteristically, psamomma bodies and endosalpingiosis are present. Endosalpingiosis is generally distinguished by the appearance of benign fallopian tube epithelium in peritoneal inclusions. A clinical history of a prior fallopian tube lesion (e.g., tubal pregnancy, hydrosalpinx, chronic salpingitis, or salpingitis isthmica nodosum) is often, but not always, present.
To clarify the significance of these primary peritoneal epithelial proliferations, we reviewed the current literature of this tumor entity focusing on clinical presentation, diagnosis, therapeutic options, and prognosis.
Case Presentation
A 32-year-old premenopausal, Caucasian woman presented with a 1-year history of infertility. She smoked and had experienced a pregnancy termination 13 years earlier. Family history was unknown as she was adopted. Sonography revealed a persistent cyst of 3 cm on the left ovary and a functional cyst on the right. The pelvic MRI detected no pelvic masses. The results of the hematological and biochemical examinations were normal. Two laparoscopies were performed: The first laparoscopy was carried out for infertility diagnostics (fallopian tube clearance and function), and biopsies of the small seedings on the peritoneum were taken in which the presence of psamomma bodies and peritoneal implants led to a suspicion of neoplasia. In the second laparoscopy, oophorectomy of the left ovary was performed in order to complete the diagnosis.
The intraoperative site ( Fig. 1 ) revealed yellowish lesions on the ovarian surface and multiple nodules and fine seeding on the whole pelvic and abdominal peritoneum. Left oophorectomy of the cystic ovary in order to exclude an ovarian borderline tumor, right salpingectomy due to nonfunction, and biopsies of the peritoneum were conducted. Biopsies from the left ovary, the pouch of Douglas peritoneum, and omentum were available for pathological examination. Microscopic examination of the submitted tissues revealed a similar pattern in all biopsy localizations. The ovary showed only minimal superficial involvement microscopically without infiltration of the ovarian stroma and no mass. The implants were confined to the surface of the peritoneum. The lesions consisted of papillary proliferations and numerous psammoma bodies in combination with minimal stromal response. The epithelial component was slightly atypical with stratification and tufting of tumor cells. Mitotic figures were absent. The right tube was not fully embedded but serial cuts were performed of the complete infundibulum (Fig. 2 ). There were no signs of invasion in any site investigated. In this case, the malignant potential according to WHO criteria was classified as borderline, and due to the absence of ovarian involvement, the tumor was defined as a case of PPSBT. Further, immunohistochemistry was positive for estrogen and progesterone receptors.
Written consent was obtained from the patient for publication of this case report and any accompanying images.
Materials and Methods
This review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [9] . A systematic search of MEDLINE and Embase was performed for articles published before May 16, 2019. Search queries included synonyms and related terms for primary peritoneal serous borderline tumor (PPSBT) as follows: ("primary peritoneal serous borderline tumor" OR "atypical endosalpingiosis" OR "primary papillary peritoneal neoplasia" OR "serous micropapillomatosis of low malignant potential" OR "intraabdominal papillomatosis" OR "serous papillary borderline tumors of the peritoneum." Reference lists of identified articles were checked to find additional relevant papers. No language restriction was placed. The following inclusion criteria were applied: patients with diagnosed or suspicion of PPSBT in histopathology and sufficient information on diagnosis and applied therapy. Exclusion criteria were concomitant gynecological carcinomas or lack of data on diagnostics therapy. Two reviewers independently performed the literature search and selection, and any disagreement was resolved by a discussion. Thus, it was debated whether the study by Genadry et al. [10] containing cases of stage 3 serous borderline ovarian tumors should be included. It is not clear whether this 35-year-old paper accurately diagnosed PPSBT; however, this largest study was included in order to mention any case of a possible PPSBT for enhancing the ability to draw conclusions on this rare tumor entity. 
Results
The study selection process is depicted in Fig. 3 . The initial literature search yielded 322 articles. After removing 124 duplicates, screening of the remaining 198 titles and abstracts yielded 25 potentially eligible original articles. After performing full-text reviews, 14 were excluded. After screening the bibliographies, four further publications were included. In total, 15 reports with 229 patients including the case of our department were found to meet the pre-defined criteria. The focus was set on patient characteristics (age, race, medical history including parity and contraception, and family history), clinics and diagnostics including symptoms, diagnostic tools, tumor grade, therapies applied (radical or limited operation, chemotherapy, radiotherapy, small molecule, and antihormonal therapy), and progression-free as well as overall survival (Tables 1, 2, and 3).
Patient Collective
The majority of women with PPSBT (over 80%) were found to be premenopausal and of an age between 30 and 40 years (middle age 38 years). Eleven studies reported parity; the majority of patients were nullipara (N = 4) or primipara (N = 4). Only Genadry et al. [10] described a predominance of multipara (62%). Concerning the medical history, 5 patients had had a previous gynecological operation, one case each due to endometriosis [6] , peritoneal Mullerian tumor [11] , or benign cyst and two cases due to cystadenoma [12, 13] . Other diseases included Behçet's disease [14] , epilepsy [11] , or diverticulosis [5] .
Only two studies described the use of contraception, one case without [11] and one with oral contraceptives for 10 and IUD for 2 years [7] . Concerning their race, 11 patients were Caucasian, whereas Genadry et al. [10] described a similar proportion of white and black patients. Family history was investigated in two single studies [7, 15] , and in one case, a grandmother had been diagnosed with breast cancer. ?, not mentioned 
Clinical Features
The clinical presentation of PPSBT comprised two main symptoms: infertility and abdominal pain. Excluding the study of Genadry et al. [10] , which did not indicate the exact number of cases for each symptom, abdominal pain was reported in 22 (29.3%) and infertility in 20 of 75 cases (26.7%).
Other symptoms of PPSBT were abdominal swelling, abnormal vaginal bleeding, a feeling of fullness, dysuria, chronic pelvic inflammatory disease, small bowel obstruction, or amenorrhea. Thirty-two percent (24/75 cases) did not show any symptoms. Fifteen of 229 cases (6.55%) were found during intrauterine (N = 10) or ectopic pregnancies (N = 3) and during caesarian section (N = 2).
Diagnostics
In general, PPSBT was diagnosed through laparotomy or laparoscopy performed due to infertility or abdominal pain. In a few cases (N = 6), the cervical smear revealed psamomma bodies followed by further diagnostic measures. Preoperative tumor markers were investigated and slightly elevated in 5 studies [7, 11, 14, 16] . Lin et al. [17] used CA-125 levels only postoperatively for follow-up. Only one study [12] reported CT findings of surgically proven PPSBT in which multiple peritoneal cysts were seen. Definitive diagnosis was established after pathological examination revealing epithelial and desmoplastic noninvasive lesions with the absence of ovarian involvement. Psammoma bodies and endosalpingiosis were found in up to 88% [1] .
Operative Description and FIGO Stage
Stages of PPSBT were divided into FIGO I-II in 169 (73.8%) and FIGO III-IV in 55 of 229 cases (24%). In the course of laparoscopy or laparotomy, most of the lesions were described as diffuse, miliary granules, or small nodules on the peritoneal and omental surfaces. Multiple adhesions were frequent. Occasionally, larger plaques and tumor masses, blebs, or cysts containing papillae were found. Ascites was present only in two cases.
Treatment
In general, treatment comprised surgery with total hysterectomy, bilateral salpingoophorectomy, and resection of all lesions in 136 cases (59.4%) or limited, fertility-saving surgery in 74 of 229 cases (32.3%). Excluding all studies which did not investigate the extent of residual disease [1, 5, 10, 18] , R0resection was achieved in 18 of 47 patients (38.3%). In the majority of cases, the lesions could be resected only to a limited extent (55.3%). ?, not mentioned ?, not mentioned Adjuvant therapy was applied in 35 cases (15.3%). Cytotoxic chemotherapy agents (N = 20) were described in two studies [10, 13] and comprised melphalan (N = 6), carboplatin, and cyclophosphamid (N = 1) or paclitaxel (N = 1). Radiotherapy was used in 15 patients, comprising two cases of intraperitoneal radioactive colloids (N = 2) [10] . Endocrine therapy was established in two women with oral contraception [6] and a progestational agent [10] . Control laparoscopies were performed after 6 months in two studies [18, 19] .
Prognosis
Follow-up periods ranged from 5 months [17] up to 16.2 years [6] . Genadry et al. [10] report three cases of a follow-up of over 30 years. An absence of recurrence was noted in up to 84% [1] . Bell et al. [1] describe two cases of recurrence after 1.7 and 2 years which were cured after repeat resection. A progression to invasive low-grade serous carcinoma of the peritoneum was described in three cases [1, 13] . Weir et al. [13] report persistent disease with survival after three laparotomies within 7.3 years.
There were 23 deaths among the follow-up periods in literature. Eighteen of these were due to intercurrent disease; only 5 were related to the intraabdominal neoplasm. One patient died of PPSBT 10 years after surgery [1] , intestinal obstruction (N = 3) [6, 10] , or in the course of adjuvant intraperitoneal therapy (N = 1) [10] .
Discussion
PPSBT are rare neoplasms with potentially malignant behavior. Patients with PPSBT are usually under the age of 40 years, although there have been cases reported in postmenopausal women [1, 6, 10] . Studies of the risk factors for developing these tumors are few, and patients' characteristics are scarcely reported. Nulliparity and infertility may increase the risk, but PPSBT have also been reported in 15 cases of pregnancy (6.55%). Only two studies investigated family history so that we cannot make a statement on hereditary factors. In our case, PPSBT was an incidental finding in the course of laparoscopy due to secondary infertility. Most likely, the infertility was caused by former infections; one tube was removed because of adhesions and nonfunction. In order to differentiate from an ovarian borderline tumor, the ovary with the persistent cyst was also removed. Due to the advanced tumor stage with multiple lesions, only R1-resection was achieved. Microscopically, noninvasive peritoneal implants and implants on the ovarian surface were found which established the diagnosis of a PPSBT. As the patient had a desire for pregnancy and was free of symptoms, GnRH analogues and antihormonal therapy were applied since the tumor showed positivity for hormone receptors. In addition, a follow-up laparoscopy was planned 6 months later.
Standard therapy options and guidelines for the treatment of PPSBT are missing. First, the rarity of cases makes controlled studies comparing different therapies difficult. Secondly, diagnosis can be difficult because of the similarities with various types of peritoneal pathologies. Pathological differential diagnosis includes endometriosis, endosalpingiosis, and benign reactive mesothelial proliferations such as adenomatoid tumor or florid mesothelial hyperplasia as well as borderline mesothelial proliferations including benign or welldifferentiated papillary mesothelioma [5] . The most important neoplastic entities in differential diagnosis are primary ovarian papillary serous borderline tumor with implants and high-grade primary peritoneal papillary serous carcinoma.
Immunohistochemistry plays an important role in routine gynecological pathology. Thus, molecular revolution has refined the knowledge of gynecological cancers as well as histological classification [20] . However, only gradual immunohistochemical differences are known in PPSBT which weakens the diagnostic importance in this tumor entity. Halperin et al. [21] compared primary peritoneal and primary ovarian serous papillary carcinoma by analyzing the immunohistochemical status of estrogen and progesterone receptors, the expression of cell proliferation marker Ki-67, and overexpression of HER-2/neu and p53 protein. Primary peritoneal neoplasms showed significantly less expression of estrogen and progesterone receptors than ovarian primary tumors. In addition, primary peritoneal neoplasms demonstrated increased expression of Ki-67 and HER-2/neu when compared with primary ovarian tumors. The data suggests that different molecular events trigger these clinically distinct tumors. To date, no similar studies have been conducted to differentiate PPSBT from ovarian SBT. Regarding these gradual immunohistochemical differences in PPSBT [21] , conventional histology in combination with the microscopy remains the most important diagnostic tool.
Further, considering the presence of endosalpingiosis in up to 88% [1] , inflammatory disorders may play an important role.
The survival rate of patients with PPSBT is comparable with the 95% survival rate for women with SBTs and noninvasive peritoneal implants who were followed for a mean interval of 6.6 years [8] . The largest study of Genadry et al. [10] reported that only two of 154 cases died of their tumor. Unfortunately, in this study, the PPSBT tumor entity included peritoneal lesions associated with SBT, which would have been classified by us as an ovarian SBT with peritoneal implants rather than a PPSBT. But even after exclusion of this study, only three cases of deaths are described during follow-up periods of 5 months to 16.2 years. Biopsy or limited surgery of PPSBT due to higher tumor stages or a desire for pregnancy does not seem to worsen the prognosis. In Bells et al.'s study series [1] , no clinical recurrence was observed in 8 patients who had limited surgical resections or peritoneal biopsies. In a study by Biscotti et al. [6] , grossly evident residual disease was present in 6 patients who did not develop a subsequent clinical recurrence. Thus, conservation of the uterus and ovaries should be considered after exclusion of an ovarian primary tumor. The risk of recurrence or transformation to low-grade serous carcinoma is low considering that only three single cases [1, 13] have been reported since the 1980s. Adjuvant therapy options such as chemotherapy or radiation were applied in 15.3%, but did not improve prognosis, suggesting that these therapeutic measures are unnecessary.
Conclusion
Data and guidelines concerning standard diagnostic and therapy options for PPSBT are still poor or missing. Infertility and abdominal pain are the leading symptoms. In contrast, in one-third of the patients, PPSBT was revealed as an incidental finding and was missing a clinical correlate. Imaging with ultrasound or pelvic CT/MRI sometimes leads to the detection of tumorous masses, blebs, or cysts, and tumor markers such as CA-125 can be elevated. Diagnosis is established during laparoscopy or laparotomy followed by histopathology. Complete surgery with meticulous removal of the lesions, if possible, seems to be a good initial option. Due to its good prognosis, conservative surgery should be considered to preserve fertility in young female patients. Additionally, in the presence of positive estrogen/progesterone receptors, GnRH analogues and complementary antihormonal therapy may be effective. However, this has not previously been observed in literature and can therefore not be recommended in PPSBT at this time. The risk of recurrence or transformation to low-grade serous carcinoma is very low, and therefore, postoperative chemotherapy or radiation therapy is not recommended. In any case, the course of the disease can comprise decades, and long-term follow-up of every PPSBT is crucial. 
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